Ligand Pharmaceuticals - 33 Year Stock Price History | LGND

Historical daily share price chart and data for Ligand Pharmaceuticals since 1992 adjusted for splits and dividends. The latest closing stock price for Ligand Pharmaceuticals as of January 16, 2025 is 111.08.
  • The all-time high Ligand Pharmaceuticals stock closing price was 274.49 on September 28, 2018.
  • The Ligand Pharmaceuticals 52-week high stock price is 129.90, which is 16.9% above the current share price.
  • The Ligand Pharmaceuticals 52-week low stock price is 67.72, which is 39% below the current share price.
  • The average Ligand Pharmaceuticals stock price for the last 52 weeks is 93.74.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Ligand Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 108.9840 108.4200 111.0800 105.8600 111.0800 3.67%
2024 92.0149 72.3100 129.9000 68.5300 107.1500 50.03%
2023 67.6952 66.0300 79.3300 49.5700 71.4200 6.92%
2022 94.5155 151.5600 151.5600 62.0000 66.8000 -56.75%
2021 139.1143 101.0700 215.8300 99.5200 154.4600 55.31%
2020 98.3573 104.7400 126.7200 63.3700 99.4500 -4.64%
2019 111.6805 137.0000 142.4700 86.2500 104.2900 -23.15%
2018 187.6862 138.6300 274.4900 128.3600 135.7000 -0.90%
2017 120.9272 102.5000 147.0400 100.3800 136.9300 34.76%
2016 108.9749 102.4700 138.5300 85.7900 101.6100 -6.28%
2015 86.5684 53.7300 111.8500 51.5400 108.4200 103.76%
2014 59.1922 51.5200 79.5800 42.3600 53.2100 1.16%
2013 37.1462 20.7200 57.9500 19.1602 52.6000 153.62%
2012 15.9545 11.9100 21.5300 11.4900 20.7400 74.73%
2011 11.4795 8.9900 15.9500 8.6500 11.8700 33.07%
2010 9.8156 13.0200 13.0200 8.2700 8.9200 -31.49%
2009 15.3079 16.2000 18.9000 9.9600 13.0200 -20.80%
2008 19.3233 29.1600 29.1600 7.6200 16.4400 -43.27%
2007 40.0625 49.1926 58.5712 23.4000 28.9800 -41.30%
2006 49.4716 51.8529 62.2356 35.8461 49.3730 -1.79%
2005 37.0503 50.5002 52.5292 21.4175 50.2748 -4.21%
2004 64.4892 67.3186 108.3049 35.4403 52.4841 -20.76%
2003 48.4792 24.6639 72.6842 16.8184 66.2364 173.56%
2002 51.9901 76.8775 90.1338 22.1389 24.2130 -70.00%
2001 54.3123 61.9980 85.6700 35.3952 80.7101 27.86%
2000 63.8520 62.5842 114.7076 44.3680 63.1252 8.70%
1999 44.1596 50.4551 62.8547 29.5787 58.0752 10.75%
1998 53.9537 57.4891 72.7293 25.9264 52.4390 -9.71%
1997 60.3340 69.2574 82.5588 41.1667 58.0752 -13.44%
1996 59.4135 46.8029 85.6700 46.2167 67.0931 38.42%
1995 35.4426 36.0716 49.5984 24.7992 48.4712 30.30%
1994 53.3798 54.1074 64.2525 28.1809 37.1988 -29.79%
1993 46.0966 55.2346 55.2346 39.4533 52.9801 11.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.008B $0.131B
Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated chemically modified cyclodextrin that is designed to improve safety and solubility, stability, and bioavailability or lessen the volatility, irritation, smell or taste of drugs. Ligand has merged with CyDex. By this, it added an antibody-generating platform, OmniAb, to the company's portfolio. Its other technology platforms include antigen discovery platform & protein expression platform. All these technologies have created a strong platform for Ligand to seek new licenses and partnerships. Ligand has partnership agreements with leading healthcare companies like Novartis, Amgen, Merck, Pfizer, Celgene, Gilead & Lilly, etc. The company continues to buy smaller companies to increase its technology platforms.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.957B 13.64
Bristol Myers Squibb (BMY) United States $113.233B 47.72
Gilead Sciences (GILD) United States $112.014B 20.29
Vertex Pharmaceuticals (VRTX) United States $105.474B 0.00
CSL (CSLLY) Australia $84.378B 0.00
Regeneron Pharmaceuticals (REGN) United States $76.580B 17.43
GSK (GSK) United Kingdom $68.581B 7.94
Argenex SE (ARGX) Netherlands $39.617B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.695B 0.00
BioNTech SE (BNTX) Germany $29.452B 0.00
Biogen (BIIB) United States $21.686B 9.31
Illumina (ILMN) United States $21.679B 79.01
BeiGene (ONC) Cayman Islands $17.250B 0.00
Moderna (MRNA) United States $16.259B 0.00
Genmab (GNMSF) Denmark $14.669B 17.59
Genmab (GMAB) Denmark $14.658B 21.50
Incyte (INCY) United States $13.590B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.841B 29.81
Sarepta Therapeutics (SRPT) United States $11.920B 107.58
Insmed (INSM) United States $11.673B 0.00
Bio-Techne Corp (TECH) United States $11.648B 44.98
Exact Sciences (EXAS) United States $10.457B 0.00
Exelixis (EXEL) United States $10.287B 23.39
QIAGEN (QGEN) Netherlands $10.196B 20.98
Vaxcyte (PCVX) United States $10.106B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Intra-Cellular Therapies (ITCI) United States $10.058B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.547B 32.45
Repligen (RGEN) United States $8.676B 113.04
Ascendis Pharma (ASND) Denmark $7.840B 0.00
Roivant Sciences (ROIV) United Kingdom $7.738B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.340B 7.18
Revolution Medicines (RVMD) United States $7.028B 0.00
Halozyme Therapeutics (HALO) United States $6.718B 15.17
Legend Biotech (LEGN) United States $6.140B 0.00
Blueprint Medicines (BPMC) United States $5.554B 0.00
Cytokinetics (CYTK) United States $5.502B 0.00
Nuvalent (NUVL) United States $5.443B 0.00
Telix Pharmaceuticals (TLX) Australia $4.897B 0.00
Alkermes (ALKS) Ireland $4.543B 15.26
Guardant Health (GH) United States $4.535B 0.00
TG Therapeutics (TGTX) United States $4.496B 0.00
Krystal Biotech (KRYS) United States $4.398B 72.82
ADMA Biologics Inc (ADMA) United States $4.387B 46.40
Viking Therapeutics (VKTX) United States $4.381B 0.00
Alvotech (ALVO) Luxembourg $4.076B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.885B 0.00
Axsome Therapeutics (AXSM) United States $3.879B 0.00
Scholar Rock Holding (SRRK) United States $3.790B 0.00
Arcellx (ACLX) United States $3.736B 0.00
Biohaven (BHVN) United States $3.713B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.672B 0.00
Avidity Biosciences (RNA) United States $3.515B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.452B 0.00
Immunovant (IMVT) United States $3.447B 0.00
Apellis Pharmaceuticals (APLS) United States $3.413B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.388B 0.00
SpringWorks Therapeutics (SWTX) United States $3.199B 0.00
Merus (MRUS) Netherlands $3.002B 0.00
NovoCure (NVCR) Jersey $2.970B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.960B 0.00
Vericel (VCEL) United States $2.937B 991.67
Xenon Pharmaceuticals (XENE) Canada $2.928B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.872B 22.13
Zai Lab (ZLAB) China $2.769B 0.00
Denali Therapeutics (DNLI) United States $2.749B 0.00
Amicus Therapeutics (FOLD) United States $2.695B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.620B 0.00
Twist Bioscience (TWST) United States $2.588B 0.00
Kymera Therapeutics (KYMR) United States $2.472B 0.00
Janux Therapeutics (JANX) United States $2.454B 0.00
Vera Therapeutics (VERA) United States $2.344B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.301B 0.00
CG Oncology (CGON) United States $2.296B 0.00
Edgewise Therapeutics (EWTX) United States $2.287B 0.00
Beam Therapeutics (BEAM) United States $2.185B 0.00
Protagonist Therapeutics (PTGX) United States $2.182B 13.76
Bavarian Nordic (BVNRY) Denmark $2.175B 13.33
IDEAYA Biosciences (IDYA) United States $2.077B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.014B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.984B 0.00
Mesoblast (MESO) Australia $1.970B 0.00
Agios Pharmaceuticals (AGIO) United States $1.963B 0.00
Iovance Biotherapeutics (IOVA) United States $1.951B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.931B 16.05
Geron (GERN) United States $1.916B 0.00
NeoGenomics (NEO) United States $1.896B 0.00
Apogee Therapeutics (APGE) United States $1.848B 0.00
Disc Medicine (IRON) United States $1.763B 0.00
WAVE Life Sciences (WVE) Singapore $1.760B 0.00
Akero Therapeutics (AKRO) United States $1.734B 0.00
Belite Bio (BLTE) United States $1.713B 0.00
Certara (CERT) United States $1.708B 48.23
Galapagos (GLPG) Belgium $1.690B 0.00
ImmunityBio (IBRX) United States $1.686B 0.00
MannKind (MNKD) United States $1.679B 43.50
Vir Biotechnology (VIR) United States $1.666B 0.00
Dynavax Technologies (DVAX) United States $1.660B 97.15
Fortrea Holdings (FTRE) United States $1.632B 51.97
Arcutis Biotherapeutics (ARQT) United States $1.616B 0.00
Celldex Therapeutics (CLDX) United States $1.615B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.521B 0.00
Novavax (NVAX) United States $1.492B 0.00
Structure Therapeutics (GPCR) United States $1.446B 0.00
Viridian Therapeutics (VRDN) United States $1.442B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.439B 0.00
Travere Therapeutics (TVTX) United States $1.412B 0.00
Myriad Genetics (MYGN) United States $1.350B 0.00
Arcus Biosciences (RCUS) United States $1.299B 0.00
Nurix Therapeutics (NRIX) United States $1.292B 0.00
Arvinas (ARVN) United States $1.279B 0.00
MiMedx (MDXG) United States $1.271B 33.27
Day One Biopharmaceuticals (DAWN) United States $1.190B 0.00
Praxis Precision Medicines (PRAX) United States $1.177B 0.00
ANI Pharmaceuticals (ANIP) United States $1.157B 15.77
Spyre Therapeutics (SYRE) United States $1.155B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.119B 0.00
Intellia Therapeutics (NTLA) United States $1.039B 0.00
Liquidia Technologies (LQDA) United States $1.032B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.015B 0.00
Adaptive Biotechnologies (ADPT) United States $0.959B 0.00
Pacira BioSciences (PCRX) United States $0.953B 8.97
Anavex Life Sciences (AVXL) United States $0.952B 0.00
CureVac (CVAC) Germany $0.943B 7.65
Nuvation Bio (NUVB) United States $0.936B 0.00
Gyre Therapeutics (GYRE) United States $0.934B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.919B 0.00
Zymeworks (ZYME) United States $0.911B 0.00
Cytek Biosciences (CTKB) United States $0.878B 0.00
Cogent Biosciences (COGT) United States $0.866B 0.00
AbCellera Biologics (ABCL) Canada $0.862B 0.00
Oculis Holding AG (OCS) Switzerland $0.857B 0.00
Castle Biosciences (CSTL) United States $0.847B 151.25
ArriVent BioPharma (AVBP) United States $0.838B 0.00
Sana Biotechnology (SANA) United States $0.817B 0.00
Septerna (SEPN) United States $0.799B 0.00
Avid Bioservices (CDMO) United States $0.794B 0.00
Bicara Therapeutics (BCAX) United States $0.783B 0.00
Tyra Biosciences (TYRA) United States $0.769B 0.00
Immatics (IMTX) Germany $0.767B 0.00
Replimune (REPL) United States $0.757B 0.00
Upstream Bio (UPB) United States $0.734B 0.00
Pliant Therapeutics (PLRX) United States $0.731B 0.00
Dianthus Therapeutics (DNTH) United States $0.716B 0.00
Prothena (PRTA) Ireland $0.702B 0.00
89BIO (ETNB) United States $0.691B 0.00
CorMedix Inc (CRMD) United States $0.679B 0.00
UniQure (QURE) Netherlands $0.675B 0.00
Erasca (ERAS) United States $0.669B 0.00
Immunome (IMNM) United States $0.662B 0.00
Pharming Group (PHAR) Netherlands $0.659B 0.00
Cullinan Therapeutics (CGEM) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
LENZ Therapeutics (LENZ) United States $0.638B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.628B 0.00
Arbutus Biopharma (ABUS) United States $0.623B 0.00
CARGO Therapeutics (CRGX) United States $0.621B 0.00
GRAIL (GRAL) United States $0.596B 0.00
Tectonic Therapeutic (TECX) United States $0.592B 0.00
Keros Therapeutics (KROS) United States $0.590B 0.00
Humacyte (HUMA) United States $0.580B 0.00
Kura Oncology (KURA) United States $0.569B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.569B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.562B 0.00
Oric Pharmaceuticals (ORIC) United States $0.562B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.551B 0.00
Entrada Therapeutics (TRDA) United States $0.548B 9.21
Rapport Therapeutics (RAPP) United States $0.542B 0.00
Emergent Biosolutions (EBS) United States $0.535B 0.00
Annexon (ANNX) United States $0.515B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.508B 0.00
Mineralys Therapeutics (MLYS) United States $0.491B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.487B 0.00
MeiraGTx Holdings (MGTX) United States $0.485B 0.00
Opthea (OPT) Australia $0.480B 0.00
Stoke Therapeutics (STOK) United States $0.477B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.475B 0.00
MaxCyte (MXCT) United States $0.465B 0.00
MBX Biosciences (MBX) United States $0.457B 0.00
GH Research (GHRS) Ireland $0.446B 0.00
Celcuity (CELC) United States $0.443B 0.00
Kodiak Sciences (KOD) United States $0.438B 0.00
AnaptysBio (ANAB) United States $0.432B 0.00
Allogene Therapeutics (ALLO) United States $0.431B 0.00
Alpha Teknova (TKNO) United States $0.430B 0.00
Cartesian Therapeutics (RNAC) United States $0.428B 0.00
Kamada (KMDA) Israel $0.426B 26.46
Terns Pharmaceuticals (TERN) United States $0.426B 0.00
PureTech Health (PRTC) United States $0.421B 0.00
Astria Therapeutics (ATXS) United States $0.420B 0.00
Abivax SA (ABVX) France $0.404B 0.00
ChromaDex (CDXC) United States $0.403B 527.00
Prime Medicine (PRME) United States $0.386B 0.00
Aura Biosciences (AURA) United States $0.380B 0.00
Third Harmonic Bio (THRD) United States $0.376B 0.00
REGENXBIO (RGNX) United States $0.372B 0.00
Codexis (CDXS) United States $0.357B 0.00
Neumora Therapeutics (NMRA) United States $0.357B 0.00
Northwest Biotherapeutics (NWBO) United States $0.354B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.350B 0.00
Eton Pharmaceuticals (ETON) United States $0.350B 0.00
Precigen (PGEN) United States $0.344B 0.00
Contineum Therapeutics (CTNM) United States $0.343B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.342B 0.00
Sage Therapeutics (SAGE) United States $0.340B 0.00
Zenas BioPharma (ZBIO) United States $0.339B 0.00
Revance Therapeutics (RVNC) United States $0.339B 0.00
EnGene Holdings (ENGN) Canada $0.336B 0.00
Alumis (ALMS) United States $0.331B 0.00
Absci (ABSI) United States $0.328B 0.00
Tango Therapeutics (TNGX) United States $0.314B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.309B 0.00
Voyager Therapeutics (VYGR) United States $0.298B 7.68
XOMA Royalty (XOMA) United States $0.297B 0.00
ATyr Pharma (ATYR) United States $0.296B 0.00
Trevi Therapeutics (TRVI) United States $0.294B 0.00
Prima BioMed (IMMP) Australia $0.293B 0.00
Chimerix (CMRX) United States $0.292B 0.00
Neurogene (NGNE) United States $0.291B 0.00
Olema Pharmaceuticals (OLMA) United States $0.289B 0.00
Rezolute (RZLT) United States $0.284B 0.00
ITeos Therapeutics (ITOS) United States $0.284B 0.00
Atea Pharmaceuticals (AVIR) United States $0.276B 0.00
AC Immune (ACIU) Switzerland $0.269B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.268B 0.00
Candel Therapeutics (CADL) United States $0.266B 0.00
C4 Therapeutics (CCCC) United States $0.259B 0.00
Design Therapeutics (DSGN) United States $0.256B 0.00
Benitec Biopharma (BNTC) United States $0.255B 0.00
Verastem (VSTM) United States $0.255B 0.00
Semper Paratus Acquisition (TVGN) United States $0.254B 0.00
BioStem Technologies (BSEM) $0.250B 22.06
Compass Therapeutics (CMPX) United States $0.244B 0.00
Sangamo Therapeutics (SGMO) United States $0.243B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.241B 0.00
Urogen Pharma (URGN) United States $0.240B 0.00
Foghorn Therapeutics (FHTX) United States $0.239B 0.00
Fulcrum Therapeutics (FULC) United States $0.236B 0.00
Lifecore Biomedical (LFCR) United States $0.233B 0.00
Ocugen (OCGN) United States $0.229B 0.00
Anika Therapeutics (ANIK) United States $0.228B 0.00
Artiva Biotherapeutics (ARTV) United States $0.227B 0.00
Amarin (AMRN) Ireland $0.227B 0.00
DiaMedica Therapeutics (DMAC) United States $0.225B 0.00
Nautilus Biotechnology (NAUT) United States $0.221B 0.00
Gossamer Bio (GOSS) United States $0.220B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.208B 0.00
ACELYRIN, INC (SLRN) United States $0.207B 0.00
Inhibrx Biosciences (INBX) United States $0.206B 0.00
TuHURA Biosciences (HURA) United States $0.205B 0.00
Molecular Partners AG (MOLN) Switzerland $0.201B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.198B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.196B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.189B 0.00
Cardiff Oncology (CRDF) United States $0.185B 0.00
Adocia (ADOCY) France $0.183B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.182B 0.00
GENFIT S.A (GNFT) France $0.180B 0.00
BioAge Labs (BIOA) United States $0.177B 0.00
Alector (ALEC) United States $0.176B 0.00
Bright Minds Biosciences (DRUG) United States $0.172B 0.00
ScPharmaceuticals (SCPH) United States $0.170B 0.00
Coherus BioSciences (CHRS) United States $0.169B 0.00
Cidara Therapeutics (CDTX) United States $0.169B 0.00
Fate Therapeutics (FATE) United States $0.167B 0.00
Nkarta (NKTX) United States $0.166B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
Adherex Technologies (FENC) United States $0.163B 0.00
Puma Biotechnology (PBYI) United States $0.162B 6.90
Actuate Therapeutics (ACTU) United States $0.162B 0.00
Sagimet Biosciences (SGMT) United States $0.159B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.159B 0.00
Checkpoint Therapeutics (CKPT) United States $0.154B 0.00
Sutro Biopharma (STRO) United States $0.153B 0.00
Akoya Biosciences (AKYA) United States $0.150B 0.00
Kyverna Therapeutics (KYTX) United States $0.149B 0.00
Caribou Biosciences (CRBU) United States $0.149B 0.00
TScan Therapeutics (TCRX) United States $0.148B 0.00
Ventyx Biosciences (VTYX) United States $0.147B 0.00
Solid Biosciences (SLDB) United States $0.147B 0.00
Innate Pharma S.A (IPHA) France $0.147B 0.00
Compugen (CGEN) Israel $0.146B 82.00
Biomea Fusion (BMEA) United States $0.144B 0.00
Seres Therapeutics (MCRB) United States $0.144B 0.00
Seer (SEER) United States $0.142B 0.00
Zura Bio (ZURA) United States $0.141B 0.00
Climb Bio (CLYM) United States $0.134B 0.00
Monopar Therapeutics (MNPR) United States $0.134B 0.00
InflaRx (IFRX) Germany $0.131B 0.00
Instil Bio (TIL) United States $0.130B 0.00
2seventy Bio (TSVT) United States $0.128B 0.00
Inozyme Pharma (INZY) United States $0.128B 0.00
Renovaro (RENB) United States $0.126B 0.00
IGM Biosciences (IGMS) United States $0.124B 0.00
INmune Bio (INMB) United States $0.122B 0.00
Aligos Therapeutics (ALGS) United States $0.121B 0.00
XBiotech (XBIT) United States $0.118B 0.00
Alto Neuroscience (ANRO) United States $0.117B 0.00
Leap Therapeutics (LPTX) United States $0.117B 0.00
Tenaya Therapeutics (TNYA) United States $0.116B 0.00
Inventiva S.A (IVA) France $0.114B 0.00
Elutia (ELUT) United States $0.113B 0.00
Nuvectis Pharma (NVCT) United States $0.112B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.111B 0.00
TELA Bio (TELA) United States $0.111B 0.00
Black Diamond Therapeutics (BDTX) United States $0.109B 0.00
Vor Biopharma (VOR) $0.107B 0.00
Jasper Therapeutics (JSPR) United States $0.106B 0.00
Editas Medicine (EDIT) United States $0.104B 0.00
Cellectis S.A (CLLS) France $0.103B 0.00
DBV Technologies S.A (DBVT) France $0.102B 0.00
HilleVax (HLVX) United States $0.102B 0.00
Cabaletta Bio (CABA) United States $0.101B 0.00
23andMe Holding (ME) United States $0.100B 0.00
BioHarvest Sciences (BHST) Canada $0.100B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.099B 0.00
X4 Pharmaceuticals (XFOR) United States $0.097B 0.00
PepGen (PEPG) United States $0.097B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
MediciNova (MNOV) United States $0.096B 0.00
Cue Biopharma (CUE) United States $0.096B 0.00
Alpha Cognition (ACOG) Canada $0.095B 0.00
Immunic (IMUX) United States $0.095B 0.00
ALX Oncology Holdings (ALXO) United States $0.093B 0.00
Atara Biotherapeutics (ATRA) United States $0.090B 0.00
Genelux (GNLX) United States $0.089B 0.00
Mersana Therapeutics (MRSN) United States $0.089B 0.00
Adverum Biotechnologies (ADVM) United States $0.089B 0.00
Aadi Bioscience (AADI) United States $0.089B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.089B 0.00
Entera Bio (ENTX) Israel $0.088B 0.00
Scilex Holding (SCLX) United States $0.087B 0.00
Genenta Science S.p.A (GNTA) Italy $0.087B 0.00
Allakos (ALLK) United States $0.087B 0.00
Theratechnologies (THTX) Canada $0.086B 0.00
Adagene (ADAG) China $0.086B 0.00
I-Mab (IMAB) China $0.086B 0.00
Skye Bioscience (SKYE) United States $0.084B 0.00
VistaGen Therapeutics (VTGN) United States $0.083B 0.00
Citius Oncology (CTOR) United States $0.082B 0.00
Bluebird Bio (BLUE) United States $0.082B 0.00
BGM Group (BGM) China $0.082B 0.00
CAMP4 Therapeutics (CAMP) United States $0.082B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.082B 0.00
Applied Therapeutics (APLT) United States $0.079B 0.00
Quince Therapeutics (QNCX) United States $0.079B 0.00
Adicet Bio (ACET) United States $0.076B 0.00
Ikena Oncology (IKNA) United States $0.075B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
Aerovate Therapeutics (AVTE) United States $0.074B 0.00
Adlai Nortye (ANL) Cayman Islands $0.073B 0.00
Vigil Neuroscience (VIGL) United States $0.073B 0.00
Agenus (AGEN) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Rani Therapeutics Holdings (RANI) United States $0.072B 0.00
Invizyne Technologies (IZTC) United States $0.071B 0.00
Abpro Holdings (ABP) United States $0.070B 0.00
Oncolytics Biotech (ONCY) Canada $0.070B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
CytomX Therapeutics (CTMX) United States $0.069B 5.18
Annovis Bio (ANVS) United States $0.067B 0.00
Galena Biopharma (SLS) United States $0.067B 0.00
Elicio Therapeutics (ELTX) United States $0.066B 0.00
FibroBiologics (FBLG) United States $0.066B 0.00
BeyondSpring (BYSI) United States $0.065B 0.00
Immuneering (IMRX) United States $0.064B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
Generation Bio (GBIO) United States $0.062B 0.00
Werewolf Therapeutics (HOWL) United States $0.062B 0.00
Connect Biopharma Holdings (CNTB) United States $0.060B 0.00
Oncobiologics (OTLK) United States $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.059B 0.00
Ovid Therapeutics (OVID) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
IO Biotech (IOBT) Denmark $0.057B 0.00
Shattuck Labs (STTK) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Invivyd (IVVD) United States $0.054B 0.00
Boundless Bio (BOLD) United States $0.054B 0.00
Spero Therapeutics (SPRO) United States $0.053B 14.00
PDS Biotechnology (PDSB) United States $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.052B 0.00
Dyadic (DYAI) United States $0.049B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.049B 0.00
Xilio Therapeutics (XLO) United States $0.048B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
Celularity (CELU) United States $0.047B 0.00
Rapt Therapeutics (RAPT) United States $0.046B 0.00
Aileron Therapeutics (ALRN) United States $0.046B 0.00
Opus Genetics (IRD) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
Precision BioSciences (DTIL) United States $0.044B 0.00
Clene (CLNN) United States $0.043B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Lantern Pharma (LTRN) United States $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Passage Bio (PASG) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
Q32 Bio (QTTB) United States $0.041B 0.00
Omega Therapeutics (OMGA) United States $0.039B 0.00
Rallybio (RLYB) United States $0.039B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.038B 0.00
Lexaria Bioscience (LEXX) Canada $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.037B 0.00
Enzo Biochem (ENZ) United States $0.036B 0.00
SAB Biotherapeutics (SABS) United States $0.035B 0.00
Promis Neurosciences (PMN) Canada $0.034B 0.00
Intensity Therapeutics (INTS) United States $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
RenovoRx (RNXT) United States $0.032B 0.00
Cognition Therapeutics (CGTX) United States $0.032B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.031B 0.00
Chemomab Therapeutics (CMMB) Israel $0.030B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
UNITY Biotechnology (UBX) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Curis (CRIS) United States $0.029B 0.00
LakeShore Biopharma (LSB) China $0.029B 0.00
Beyond Air (XAIR) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.027B 0.00
Longeveron (LGVN) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
BioAtla (BCAB) United States $0.026B 0.00
OnKure Therapeutics (OKUR) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Exicure (XCUR) United States $0.025B 0.00
Prana Biotechnology (ATHE) Australia $0.024B 0.00
Pluri (PLUR) Israel $0.024B 0.00
IN8bio (INAB) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Gelteq (GELS) Australia $0.022B 0.00
NextCure (NXTC) United States $0.022B 0.00
Ocean Biomedical (OCEA) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Athira Pharma (ATHA) United States $0.022B 0.00
Cara Therapeutics (CARA) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Bolt Biotherapeutics (BOLT) United States $0.021B 0.00
Aprea Therapeutics (APRE) United States $0.020B 0.00
Affimed (AFMD) Germany $0.019B 0.00
BioXcel Therapeutics (BTAI) United States $0.019B 0.00
Palvella Therapeutics (PVLA) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
BRIACELL THERAP (BCTX) Canada $0.018B 0.00
MetaVia (MTVA) United States $0.018B 0.00
NKGen Biotech (NKGN) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Spruce Biosciences (SPRB) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Aptose Biosciences (APTO) Canada $0.013B 0.00
Hoth Therapeutics (HOTH) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
CervoMed (CRVO) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.013B 0.00
BioAffinity Technologies (BIAF) United States $0.013B 0.00
Mustang Bio (MBIO) United States $0.012B 0.00
Eyenovia (EYEN) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Apollomics (APLM) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
Carmell (CTCX) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Mainz Biomed (MYNZ) Germany $0.009B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Silo Pharma (SILO) United States $0.008B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Vincerx Pharma (VINC) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00